Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study).

Shimizu T, Kawashiri SY, Koga T, Kiya R, Morita M, Kawasaki R, Kuroda S, Tashiro S, Sato S, Yabe M, Misaki K, Hanai S, Nakagomi D, Ogasawara M, Tamura N, Watanabe R, Kanazawa H, Atsumi T, Ueki Y, Okano T, Suzuki T, Takaoka H, Hamada H, Hidaka T, Furuta S, Hosogaya N, Yamamoto H, Kawakami A

Open source

DOI: 10.5582/ddt.2026.01008
Published: 2026 May 17
Container: Drug discoveries & therapeutics
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.5582/ddt.2026.01008,
  title = {Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study).},
  author = {Shimizu T and Kawashiri SY and Koga T and Kiya R and Morita M and Kawasaki R and Kuroda S and Tashiro S and Sato S and Yabe M and Misaki K and Hanai S and Nakagomi D and Ogasawara M and Tamura N and Watanabe R and Kanazawa H and Atsumi T and Ueki Y and Okano T and Suzuki T and Takaoka H and Hamada H and Hidaka T and Furuta S and Hosogaya N and Yamamoto H and Kawakami A},
  year = {2026},
  journal = {Drug discoveries \& therapeutics},
  doi = {10.5582/ddt.2026.01008},
  url = {https://doi.org/10.5582/ddt.2026.01008}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study).
AU  - Shimizu T
AU  - Kawashiri SY
AU  - Koga T
AU  - Kiya R
AU  - Morita M
AU  - Kawasaki R
AU  - Kuroda S
AU  - Tashiro S
AU  - Sato S
AU  - Yabe M
AU  - Misaki K
AU  - Hanai S
AU  - Nakagomi D
AU  - Ogasawara M
AU  - Tamura N
AU  - Watanabe R
AU  - Kanazawa H
AU  - Atsumi T
AU  - Ueki Y
AU  - Okano T
AU  - Suzuki T
AU  - Takaoka H
AU  - Hamada H
AU  - Hidaka T
AU  - Furuta S
AU  - Hosogaya N
AU  - Yamamoto H
AU  - Kawakami A
PY  - 2026
JO  - Drug discoveries & therapeutics
DO  - 10.5582/ddt.2026.01008
UR  - https://doi.org/10.5582/ddt.2026.01008
ER  -

APA

T, S., SY, K., T, K., R, K., M, M., R, K., S, K., S, T., S, S., M, Y., K, M., S, H., D, N., M, O., N, T., R, W., H, K., T, A., Y, U., T, O., T, S., H, T., H, H., T, H., S, F., N, H., H, Y., & A, K. (2026). Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study).. Drug discoveries & therapeutics. https://doi.org/10.5582/ddt.2026.01008

Source records

pubmed · retrieved 2026-09-26T12:00:38.084Z
europe-pmc · retrieved 2026-09-26T12:00:38.078Z